M
Martin J. Abrahamson
Researcher at Beth Israel Deaconess Medical Center
Publications - 61
Citations - 4600
Martin J. Abrahamson is an academic researcher from Beth Israel Deaconess Medical Center. The author has contributed to research in topics: Diabetes mellitus & Type 2 diabetes. The author has an hindex of 24, co-authored 60 publications receiving 4091 citations. Previous affiliations of Martin J. Abrahamson include Joslin Diabetes Center & Harvard University.
Papers
More filters
Journal ArticleDOI
Consensus statement by the american association of clinical endocrinologists and american college of endocrinology on the comprehensive type 2 diabetes management algorithm--2016 executive summary.
Alan J. Garber,Martin J. Abrahamson,Joshua I. Barzilay,Lawrence Blonde,Zachary T. Bloomgarden,Michael A. Bush,Samuel Dagogo-Jack,Ralph A. DeFronzo,Daniel Einhorn,Vivian Fonseca,Jeffrey R. Garber,W. Timothy Garvey,George Grunberger,Yehuda Handelsman,Robert R. Henry,Irl B. Hirsch,Paul S. Jellinger,Janet B. McGill,Jeffrey I. Mechanick,Paul D. Rosenblit,Guillermo E. Umpierrez +20 more
TL;DR: This chapter discusses the development and use of eicosapentaenoic acid as a treatment for diabetic ketoacidosis and its applications in conventional and regenerative medicine.
Journal ArticleDOI
Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2018 Executive Summary
Alan J. Garber,Martin J. Abrahamson,Joshua I. Barzilay,Joshua I. Barzilay,Lawrence Blonde,Zachary T. Bloomgarden,Michael A. Bush,Michael A. Bush,Samuel Dagogo-Jack,Ralph A. DeFronzo,Daniel Einhorn,Vivian Fonseca,Jeffrey R. Garber,W. Timothy Garvey,George Grunberger,Yehuda Handelsman,Irl B. Hirsch,Paul S. Jellinger,Janet B. McGill,Jeffrey I. Mechanick,Jeffrey I. Mechanick,Jeffrey I. Mechanick,Paul D. Rosenblit,Guillermo E. Umpierrez,Guillermo E. Umpierrez +24 more
TL;DR: The objective of the trial was to establish whether or not the initial treatment strategy improved the patient’s quality of life and/or lowered the risk of adverse events.
Journal ArticleDOI
AACE comprehensive diabetes management algorithm 2013.
Alan J. Garber,Martin J. Abrahamson,Joshua I. Barzilay,Lawrence Blonde,Zachary T. Bloomgarden,Michael A. Bush,Samuel Dagogo-Jack,Michael B. Davidson,Daniel Einhorn,W. Timothy Garvey,George Grunberger,Yehuda Handelsman,Irl B. Hirsch,Paul S. Jellinger,Janet B. McGill,Jeffrey I. Mechanick,Paul D. Rosenblit,Guillermo E. Umpierrez,Michael H. Davidson +18 more
Journal ArticleDOI
Consensus statement by the american association of clinical endocrinologists and american college of endocrinology on the comprehensive type 2 diabetes management algorithm - 2017 executive summary
Alan J. Garber,Martin J. Abrahamson,Joshua I. Barzilay,Lawrence Blonde,Zachary T. Bloomgarden,Michael A. Bush,Samuel Dagogo-Jack,Ralph A. DeFronzo,Daniel Einhorn,Vivian Fonseca,Jeffrey R. Garber,W. Timothy Garvey,George Grunberger,Yehuda Handelsman,Irl B. Hirsch,Paul S. Jellinger,Janet B. McGill,Jeffrey I. Mechanick,Paul D. Rosenblit,Guillermo E. Umpierrez +19 more
TL;DR: This monograph describes the development and use of various strategies to reduce the risk of heart attack and stroke in patients with type 2 diabetes through a variety of treatments, including vaccination, diet and lifestyle modifications.
Journal ArticleDOI
Consensus statement by the american association of clinical endocrinologists and american college of endocrinology on the comprehensive type 2 diabetes management algorithm - 2020 executive summary.
Alan J. Garber,Yehuda Handelsman,George Grunberger,Daniel Einhorn,Martin J. Abrahamson,Joshua I. Barzilay,Lawrence Blonde,Michael A. Bush,Ralph A. DeFronzo,Jeffrey R. Garber,W. Timothy Garvey,Irl B. Hirsch,Paul S. Jellinger,Janet B. McGill,Jeffrey I. Mechanick,Leigh Perreault,Paul D. Rosenblit,Susan L. Samson,Guillermo E. Umpierrez +18 more
TL;DR: The objective of this study was to establish a baseline for the development of a strategy to manage the inflammatory bowel disease-related complications of type 2 diabetes using a proprotein convertase-like mechanism.